Good morning. Welcome to Axios today. It's Wednesday, September 8th. I'm Nailiburu. Here's

what you need to know today. Mexico moves to decriminalize abortion. Plus, Latino voters

roll in deciding the fate of California Governor Gavin Newsom. But first, looking to new vaccines

for a way out of COVID is today's one big thing.

Here in the US, the COVID vaccine conversation has mostly been focused on Pfizer, Moderna, and

the Johnson & Johnson vaccines. But with Delta's strong hold on much of the US, Axios'

healthcare business reporter Bob Herman reports, we might need to look to other emerging

vaccines. And he's here to tell us more about that. Hey, Bob. Hey, Nailib. Bob, I remember

way back in the beginning, we were talking about all the other vaccine manufacturers. Where

are they at this stage in the pandemic? So there's about six or seven vaccines that are being used

globally. Obviously, more are being studied and a child right now because even with this number

of different vaccines, we're still not even remotely close to fully vaccinating the world. So I

think there's quite a bit of pressure to find a vaccine that can just be more widely distributed.

We have been talking so much about Moderna, Pfizer, Johnson, and Johnson. There's another vaccine

you've been watching Corbivax. So this vaccine Corbivax was developed in Texas and they're already

licensing out the technology. It's undergoing clinical trials and the great benefit is that Corbivax

uses traditional vaccine technology that's used in the hepatitis B vaccine, for example,

instead of the newer, more expensive technology. So that could be scaled up quickly. And the other

good news is researchers say it's very cheap. It could be $1.50 a dose. Is the Biden administration

paying attention to the Corbivax? So far, not really. The researchers have tried asking

administration to get involved and not a whole lot has panned out yet. So I think there's a role

for the U.S. to play here. Researchers have been getting interest from other countries for

...